UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears

The Journal of dermatological treatment, 2020-05, Vol.31 (4), p.328-329

2020

Volltextzugriff (PDF)

Human Microbiome: Composition and Role in Inflammatory Skin Diseases

Archivum Immunologiae et Therapiae Experimentalis, 2019-02, Vol.67 (1), p.1-18

2019

Volltextzugriff (PDF)

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

The Journal of dermatological treatment, 2022-01, Vol.33 (1), p.592-592

2022

Volltextzugriff (PDF)

Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa

Dermatologic therapy, 2020-07, Vol.33 (4), p.e13756-e13756

2020

Volltextzugriff (PDF)

Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience

Supportive care in cancer, 2020-09, Vol.28 (9), p.3991-3993

2020

Volltextzugriff (PDF)

Hidradenitis Suppurativa: Where We Are and Where We Are Going

Cells (Basel, Switzerland), 2021-08, Vol.10 (8), p.2094

2021

Volltextzugriff (PDF)

Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity

The Journal of dermatological treatment, 2021-10, Vol.32 (7), p.843-844

2021

Volltextzugriff (PDF)

Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case

International wound journal, 2019-08, Vol.16 (4), p.1047-1048

2019

Volltextzugriff (PDF)

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1511

2022

Volltextzugriff (PDF)

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report

Case reports in dermatology, 2023-01, Vol.15 (1), p.35-39

2023

Volltextzugriff (PDF)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis

Journal of clinical medicine, 2023-01, Vol.12 (3), p.837

2023

Volltextzugriff (PDF)

Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients' quality of life

The Journal of dermatological treatment, 2022-04, Vol.33 (3), p.1-1737

2022

Volltextzugriff (PDF)

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus

Case reports in dermatology, 2020-08, Vol.12 (2), p.155-158

2020

Volltextzugriff (PDF)

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab

Case reports in dermatology, 2022-05, Vol.14 (2), p.138-143

2022

Volltextzugriff (PDF)

Reply to Borgia et al. Comment on "Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11 , 1511"

Journal of clinical medicine, 2022-07, Vol.11 (14), p.4244

2022

Volltextzugriff (PDF)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series

JAAD Case Reports, 2022-05, Vol.23, p.42-45

2022

Volltextzugriff (PDF)

Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study

Dermatology and therapy, 2024-08, Vol.14 (8), p.2077-2092

2024

Volltextzugriff (PDF)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series

Dermatologic therapy, 2022-02, Vol.35 (2), p.e15225-n/a

2022

Volltextzugriff (PDF)

Nodular cutaneous amyloidoma of the extremity secondary to chronic granulomatous inflammation in setting of sarcoidosis

Journal of cutaneous pathology, 2017-09, Vol.44 (9), p.801-804

2017

Volltextzugriff (PDF)

Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’

Journal of the European Academy of Dermatology and Venereology, 2023-01, Vol.37 (1), p.e43-e44

2023

Volltextzugriff (PDF)

Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’

Clinical and experimental dermatology, 2022-10, Vol.47 (10), p.1864-1865

2022

Volltextzugriff (PDF)

Management of patients with hidradenitis suppurativa during COVID‐19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID‐19 vaccination in patients with hidradenitis suppurativa’

Clinical and experimental dermatology, 2022-11, Vol.47 (11), p.2026-2028

2022

Volltextzugriff (PDF)

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?

Medical hypotheses, 2020-10, Vol.143, p.109853-109853, Article 109853

2020

Volltextzugriff (PDF)

Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'

Clinical and experimental dermatology, 2023-06, Vol.48 (6), p.701-703

2023

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(149)
Berichte
(21)

Sprache

Englisch
(170)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears

Human Microbiome: Composition and Role in Inflammatory Skin Diseases

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa

Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience

Hidradenitis Suppurativa: Where We Are and Where We Are Going

Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity

Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis

Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients' quality of life

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab

Reply to Borgia et al. Comment on "Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11 , 1511"

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series

Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study

Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series

Nodular cutaneous amyloidoma of the extremity secondary to chronic granulomatous inflammation in setting of sarcoidosis

Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’

Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’

Management of patients with hidradenitis suppurativa during COVID‐19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID‐19 vaccination in patients with hidradenitis suppurativa’

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?

Suchergebnisse filtern